AlphAIalphai — Financial news for AI agents
financialcontent.comJUL 285 min read$CHE

Chemed (NYSE:CHE) Exceeds Q2 CY2026 Expectations

Chemed Corp (NYSE:CHE) reported Q2 CY2026 revenue of $673.3 million, up 8.8% year on year and 1.2% above Wall Street estimates, and non-GAAP EPS of $6.06, 8.2% above consensus. Analysts expect revenue growth of about 7% and full-year EPS to rise from $23.40 to $25.61.

Original reporting
financialcontent.com
Published Jul 28, 2026, 9:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 28, 2026, 9:57 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Chemed (NYSE:CHE) Exceeds Q2 CY2026 Expectations — source image
Source · financialcontent.com
Decision brief

The 30-second read

$CHEBullishMed
01

Why it matters

Q2 CY2026 results beat consensus on revenue and non-GAAP EPS, with adjusted operating margin improving year over year, which can influence near-term estimate revisions and positioning.

02

Market read

Traders can reassess near-term expectations given the quantified beat versus Wall Street estimates and the stated forward EPS growth range.

03

What to watch

No detail is provided on cash flow quality, hospice utilization trends, or Roto-Rooter demand drivers, which could determine whether the beat leads to estimate upgrades.

Relevance 7/10Novelty 6/10Timing: after-hours/late-day following Q2 CY2026 results release

Background

Chemed operates VITAS hospice care and Roto-Rooter plumbing and water restoration services, and reports billable days as an operating metric.

Company-level read

Ticker impact

$CHEBullishMedium confidence
Context

Chemed reported Q2 CY2026 revenue of $673.3M (+8.8% YoY) and non-GAAP EPS $6.06, both beating consensus estimates.

Expected impact

Likely near-term positive bias versus peers, with follow-through dependent on whether the beat translates into upward revisions.

Evidence & confidence

The article provides specific beat metrics (revenue +1.2% vs estimates, EPS +8.2% vs estimates) and cites a forward EPS growth expectation, but it does not include management guidance or a new revision event.

Market effects

Sector

Hospice and household services demand signals remain supportive, but the article does not provide sector-wide guidance changes.

Regional

No regional macro or policy drivers are discussed.

Global

No global supply chain or international demand factors are mentioned.

Counterpoint

What could challenge this read

The article notes weaker longer-term profitability trends (margin down over five years), so the beat may reflect temporary efficiency rather than durable re-acceleration.

Key entities

  • company
    Chemed Corporation

    Healthcare services company with VITAS hospice and Roto-Rooter services; reported Q2 CY2026 results.

  • business_unit
    VITAS

    Chemed hospice care segment referenced in the company overview.

  • business_unit
    Roto-Rooter

    Chemed plumbing and water restoration segment referenced in the company overview.

Read at source← All news

Related articles

JUL 28
$CHEMed

CHEMED CORP (CHE): Results of Operations and Financial Condition

CHEMED CORP (CHE) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99 2 che-20260728xex99.htm EX-99 Exhibit 99 CONTACT: Michael D. Witzeman (513) 762- 6714  Chemed Reports Second-Quarter 2026 Results  Full-Year Guidance Increased Due Mainly to VITAS Outperformance   CINCINNATI, July 28, 2026— Chemed Corporation (Chemed) (NYSE: CHE ), whic

SEC EDGAR 8-K6 min
JUN 8
$CHEMed

Roto-Rooter Buys Franchise Territory in Corpus Christi, Rio Grande Valley, and Beaumont, Texas

Chemed Corp. (NYSE: CHE) said its wholly owned Roto-Rooter unit acquired an independent Roto-Rooter franchise covering 21 south Texas counties, including Corpus Christi, McAllen, Laredo and Brownsville, for about $12.0 million. The company operates Roto-Rooter plumbing and drain cleaning services and VITAS hospice care. The release includes standard forward-looking statement cautions.

manilatimes.net2 min
AUG 9
$MURMedAI 8/10

Murphy Oil Sees Sharp Profit Increase

Murphy Oil Corp reported Q2 2026 adjusted net income of $225.8 million, nearly six times Q2 2025, as higher oil prices offset lower production and weaker gas. Adjusted EPS was $1.55 vs $1.51 consensus. Revenue rose to $926.3 million. Murphy kept its $0.35 dividend and raised 2026 capex midpoint to $1.55 billion.

peakoil.com4 min
AUG 9
$GSBDMed

Goldman Sachs BDC Q2 Earnings Call Highlights

Goldman Sachs BDC (NYSE:GSBD) reported no incentive fee in Q2, citing its three-year total-return lookback provision. NAV was $12.06/share at June 30 vs $12.17 in Q1. The board declared a Q3 base dividend of $0.32/share plus $0.03 supplemental. Investments were $3.2B fair value, non-accrual 2.9%, and net debt-to-equity 1.35x.

yahoo.com6 min
AUG 9
$HBBMed

Hamilton Beach Brands Q2 Earnings Call Highlights

Hamilton Beach Brands (HBB) reported Q2 gross margin of 26.1% excluding tariff-related benefits, and said it expects 2026 revenue growth in the mid-single-digit range. Management forecast full-year gross margin to improve modestly and operating profit to decline by a high-single-digit percentage. Operating cash flow is expected at $35M to $45M. HBB ended with net cash of $51.5M.

yahoo.com5 min
AUG 9
$GXOMed

GXO Logistics Q2 Earnings Call Highlights

GXO Logistics reported Q2 results and said it secured over $1 billion in expected incremental new-business revenue for 2026 and about $353 million for 2027. Management cited a $2.7 billion sales pipeline after quarter end. Operating cash flow was $76 million, free cash flow positive $12 million, cash $769 million, and net leverage 2.6x. GXO plans to target EBIT margins above 6% and deploy AI across ~50 sites in 2026.

yahoo.com6 min